Nevola R, Epifani R, Imbriani S, Tortorella G, Aprea C, Galiero R, Rinaldi L, Marfella R, Sasso FC
10.1111/jcmm.14511 49
Food and Drug Administration approved tirzepatide weekly injections for chronic weight management in adults who are overweight or have obesity, with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol), in addition to a reduced calorie diet and increased physical activity in November 2023
Despite three decades of preclinical research, not a single human clinical trial exists for mental health applications
But restoring health is a more complicated process than simply supplementing with the right peptides in the right amounts